Patents Assigned to Lazure Scientific, Inc.
  • Patent number: 9775671
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: October 3, 2017
    Assignee: LaZure Scientific, Inc.
    Inventor: Larry Azure
  • Patent number: 9526911
    Abstract: Systems and methods for delivering electric fields to a target tissue of a patient for destruction of cancerous cells so as to elicit or induce a specific anti-cancerous cell immune response in the patient.
    Type: Grant
    Filed: April 27, 2011
    Date of Patent: December 27, 2016
    Assignee: LAZURE SCIENTIFIC, INC.
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure, Rafael Ponce, Lawrence L. Kunz
  • Patent number: 9308039
    Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.
    Type: Grant
    Filed: January 5, 2012
    Date of Patent: April 12, 2016
    Assignee: LaZure Scientific, Inc.
    Inventor: Larry Azure
  • Publication number: 20140303613
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Application
    Filed: March 31, 2014
    Publication date: October 9, 2014
    Applicants: LaZure Scientific, Inc., LaZure Technologies, LLC
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Patent number: 8728139
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: May 20, 2014
    Assignees: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Publication number: 20120232550
    Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.
    Type: Application
    Filed: January 5, 2012
    Publication date: September 13, 2012
    Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventor: Larry Azure
  • Patent number: 8109926
    Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: February 7, 2012
    Assignees: Lazure Scientific, Inc., Lazure Technologies, LLC
    Inventor: Larry Azure
  • Patent number: 7979121
    Abstract: An electromagnetic device and method of operation thereof are disclosed. The electromagnetic device contains an electromagnetic field generator, a microcurrent generator and a photonic accumulator. The electromagnetic field generator generates broadband electromagnetic fields to substantially envelope a subject placed in proximity thereto. The subject is placed in contact with microcurrent electrodes so as to permit a broadband microcurrent to flow through the subject or along the surface of the subject. A photonic accumulator is positioned proximate the subject to receive biophotons emitted therefrom and to activate the biophotons with a light source.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: July 12, 2011
    Assignee: Lazure Scientific, Inc.
    Inventor: Larry Azure
  • Publication number: 20110060393
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Application
    Filed: April 16, 2010
    Publication date: March 10, 2011
    Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Publication number: 20090076502
    Abstract: Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicants: LaZure Technologies, LLC., LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles Hill, Andrew L. Azure